Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07854769) titled 'Blood Testing to Detect Cancer Recurrence in Patients With Early-Stage Non-Small Cell Lung Cancer' on Sept. 28.

Study Type: Observational

Primary Sponsor: Fox Chase Cancer Center

Condition: Non Small Cell Lung Cancer

Recruitment Status: Not recruiting

Date of First Enrollment: October 6, 2026

Target Sample Size: 200

To know more, visit https://clinicaltrials.gov/study/NCT07854769

Published by HT Digital Content Services with permission from Health Daily Digest....